Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Salt Industry Group is the largest salt producer and supplier in Asia and the second largest globally. It operates as a state-owned monopoly in China's salt industry, controlling production and distribution of edible and industrial salts. The group also has significant operations in inorganic chemicals, fine chemicals, building materials, polymer materials, and some biopharmaceuticals through its subsidiaries. Its main business remains focused on salt production and related chemical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Salt Chemical.